AMD vs NBIX · P/E 157, rev $11.54B vs P/E 45, rev $2.36B
Advanced Micro Devices Inc (AMD) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AMD and NBIX stock pages for the full models.
Not investment advice.